WC, S., W, L., H, S., KY, L., SH, J., YJ, C., . . . BH, L. (2020). Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease. Metabolism: clinical and experimental, 102, 154000. https://doi.org/10.1016/j.metabol.2019.154000
Chicago Style (17th ed.) CitationWC, Sim, et al. "Downregulation of PHGDH Expression and Hepatic Serine Level Contribute to the Development of Fatty Liver Disease." Metabolism: Clinical and Experimental 102 (2020): 154000. https://doi.org/10.1016/j.metabol.2019.154000.
MLA (9th ed.) CitationWC, Sim, et al. "Downregulation of PHGDH Expression and Hepatic Serine Level Contribute to the Development of Fatty Liver Disease." Metabolism: Clinical and Experimental, vol. 102, 2020, p. 154000, https://doi.org/10.1016/j.metabol.2019.154000.